Back to search
Multi-Drug Resistant Organism Colonization
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Multi-Drug Resistant Organism Colonization trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Multi-Drug Resistant Organism Colonization trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this study is to better understand the effectiveness and safety of microbiome therapies (MT) as a treatment for patients with Multidrug Resistant…
REACT is a phase two, open-label, randomized, controlled trial of microbiota therapy (MT) to reduce colonization with multi-drug resistant organisms (MDRO). REA…
The goal of this clinical trial is to test whether lyophilized fecal microbime transfer - a dried extract of bacteria from the stool of healthy donors - is bett…
This proposed protocol involves the use of the fecal microbiota transplantation (FMT) to suppress or reverse colonization with multidrug resistant organisms (MD…